LifeMine is mining the biosphere to discover disruptively innovative drugs. The biotech has built a first-of-its-kind genomically-enabled drug discovery platform that can rapidly develop new drugs from fungi. Co-founded in 2017 by academic scientist, biotech entrepreneur, investor, and chief executive Gregory Verdine, LifeMine aims to develop drugs for previously untreatable and significant chronic diseases. The company is headquartered in Boston.